fashion -WSS

fashion

author：explore 2025-09-06 06:51:21 - browse：575

The corporate offices of Massachusetts General Brigham hospitals in Assembly Square in Somerville. Lane Turner/Globe Staff

The severing of ties between two of Boston’s biggest health care giants has placed one of the nation’s largest health care systems in the position of figuring out how, exactly, to fill a new hole in its oncology services, at a time when cancer care is changing rapidly.

Earlier this month, Dana-Farber Cancer Institute surprised the medical community and even its partner, Brigham and Women’s Hospital, when it announced that it would end their nearly 30-year collaboration. The split will take a few years to play out — Dana-Farber and Brigham and Women’s have a contract into 2028 — but has shaken patients and physicians.

Anne Klibanski, chief executive of Brigham and Women’s parent organization, Mass General Brigham, placed the blame on Dana-Farber executives. The two parties had been in discussions about extending their contract for months when the split was announced. “The decision was made by the Farber. It was announced. Now, we just have to plan forward,” she said. Klibanski shared her views on the split at a meeting with Boston Globe opinion editors on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Florida Supreme Court upholds state's abortion ban

WSS

Scientific mystery highlights the blind spots in genomics databases

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Young boy dies in trial for Pfizer Duchenne gene therapy

Antivenom research: Lessons from HIV applied in search for universal antidote

Harvard scientists, with Google, unveil the most detailed brain map ever

Trial using CRISPR to edit HIV out of cells disappoints

entertainment

fashion

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Bird flu in dairy cattle: New measures to control spread to humans

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Obesity drugs seen as possible treatment for liver disease MASH

In age of alternative facts, a scholarly course on calling out crap

Alabama IVF ruling threatens families facing fatal genetic disease

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Trial using CRISPR to edit HIV out of cells disappoints

BioMarin wins approval for gene therapy to treat hemophilia A

PBM reform efforts get punted in Congress

hotspot

Covid silver lining: Unprecedented look at human immune system

Why palliative psychiatry is worth discussing

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Medicare inequities exacerbate Puerto Rico’s health disparities

Scientists uncover potential path to treating deadly childhood tumor

Covid silver lining: Unprecedented look at human immune system

Wikipedia

explore

knowledge

hotspot